Inspire Medical Systems Income After Taxes 2017-2025 | INSP

Inspire Medical Systems income after taxes from 2017 to 2025. Income after taxes can be defined as earnings or losses after income tax expense but before minority interest, extraordinary items, discontinued operations, preferred dividends and accounting changes have been accounted for.
Inspire Medical Systems Annual Income After Taxes
(Millions of US $)
2024 $54
2023 $-21
2022 $-45
2021 $-42
2020 $-57
2019 $-33
2018 $-22
2017 $-18
2016 $-19
Inspire Medical Systems Quarterly Income After Taxes
(Millions of US $)
2025-03-31 $3
2024-12-31 $35
2024-09-30 $18
2024-06-30 $10
2024-03-31 $-10
2023-12-31 $15
2023-09-30 $-9
2023-06-30 $-12
2023-03-31 $-15
2022-12-31 $3
2022-09-30 $-17
2022-06-30 $-14
2022-03-31 $-17
2021-12-31 $-2
2021-09-30 $-10
2021-06-30 $-13
2021-03-31 $-16
2020-12-31 $-7
2020-09-30 $-10
2020-06-30 $-23
2020-03-31 $-16
2019-12-31 $-9
2019-09-30 $-8
2019-06-30 $-8
2019-03-31 $-8
2018-12-31 $-5
2018-09-30 $-5
2018-06-30 $-6
2018-03-31 $-7
2017-12-31 $-4
2017-09-30 $-4
2017-06-30 $-5
2017-03-31 $-4
2016-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $3.905B $0.803B
Inspire Medical Systems Inc. is a medical technology company. It focused on the development and commercialization of solutions for obstructive sleep apnea. The company's proprietary Inspire therapy is a neurostimulation technology which provides treatment for moderate to severe obstructive sleep apnea. Inspire Medical Systems Inc.is based in Minnesota, United States.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $46.313B 58.92
Tempus AI (TEM) United States $11.516B 0.00
Doximity (DOCS) United States $11.474B 53.12
Hims & Hers Health (HIMS) United States $11.060B 114.91
IRhythm Technologies (IRTC) United States $4.939B 0.00
Hinge Health (HNGE) United States $3.629B 0.00
Privia Health (PRVA) United States $2.682B 183.33
Enovis (ENOV) United States $1.815B 10.12
Phreesia (PHR) United States $1.695B 0.00
Schrodinger (SDGR) United States $1.512B 0.00
10x Genomics (TXG) United States $1.444B 0.00
Clover Health Investments (CLOV) United States $1.405B 0.00
Azenta (AZTA) United States $1.400B 65.08
Omnicell (OMCL) United States $1.376B 24.28
Evolent Health (EVH) United States $1.310B 111.60
Claritev (CTEV) United States $0.716B 0.00
Fulgent Genetics (FLGT) United States $0.599B 0.00
Veradigm (MDRX) United States $0.498B 0.00
Butterfly Network (BFLY) United States $0.485B 0.00
Talkspace (TALK) United States $0.463B 138.50
Standard BioTools (LAB) United States $0.452B 0.00
TruBridge (TBRG) United States $0.349B 773.33
Outset Medical (OM) United States $0.338B 0.00
Health Catalyst (HCAT) United States $0.265B 0.00
Nyxoah SA (NYXH) Belgium $0.254B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.206B 0.00
KORU Medical Systems (KRMD) United States $0.167B 0.00
EUDA Health Holdings (EUDA) Singapore $0.127B 0.00
American Well (AMWL) United States $0.124B 0.00
MDxHealth SA (MDXH) Belgium $0.109B 0.00
Pulmonx (LUNG) United States $0.105B 0.00
CareCloud (CCLD) United States $0.102B 3.89
Insight Molecular Diagnostics (IMDX) United States $0.092B 0.00
111 (YI) China $0.060B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.051B 0.00
HeartBeam (BEAT) United States $0.046B 0.00
P3 Health Partners (PIII) United States $0.046B 0.00
Zepp Health (ZEPP) Netherlands $0.037B 0.00
Zhongchao (ZCMD) China $0.029B 0.00
Streamline Health Solutions (STRM) United States $0.023B 0.00
Precipio (PRPO) United States $0.016B 0.00
Bullfrog AI Holdings (BFRG) United States $0.014B 0.00
MSP Recovery (MSPR) United States $0.010B 0.00
Healthcare Triangle (HCTI) United States $0.009B 0.00
Strata Skin Sciences (SSKN) United States $0.009B 0.00
Predictive Oncology (POAI) United States $0.007B 0.00
Movano (MOVE) United States $0.005B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Evaxion - (EVAX) Denmark $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00